JNJ (NYSE: JNJ) to Buy 18.4% Stake In Elan (NYSE: ELN) for $1B
More News related to ELN
- Elan Drug Technologies Announces Submission by Janssen-Cilag of Marketing Authorisation Application in Europe for Paliperidone Palmitate for the Treatment of Schizophrenia using Elan's NanoCrysta
- El Nino Closes $1.5 Million Non-Brokered Private Placement; Update on the Kasala Copper Project in the DRC
- The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments
- Elan to Present at Lazard Capital Markets 6th Annual Healthcare Conference
- Elan Corporation Plc Announces Expiration of Tender Offer for 73/4% Senior Fixed Rate Notes Due 2011
More News related to JNJ
- Emerging Healthcare Launches Health Initiative
- ASP Announces Acquisition of Gloster Europe to Help Reduce Infections in Healthcare Facilities
- StockPreacher.com Issues Trading Outlook for Arena Pharmaceuticals Inc.
- Emerging Agents from Theravance/Astellas, Johnson & Johnson/Basilea and Forest/Astrazeneca/Takeda Will Drive Modest Growth in the MRSA Drug Market Through 2018
- Trading Outlook for BioElectronics Corporation Issued by StockPreacher.com
More News related to Mergers and Acquisitions
- Metalline Mining (MMG) and Dome Ventures Agree to Merger Deal
- Pepsi (PEP) Company Completes Acquisition of Conway-Myrtle Beach Bottler
- Hershey (HSY), Nestle said to have been in contact about Cadbury (CBY)
- Kraft Singles Itself Out as Buyer for Cadbury
- Brookfield Positions To Bid for General Growth Properties (GGWPQ)
JNJ (NYSE: JNJ) to Buy 18.4% Stake In Elan (NYSE: ELN) for $1B
Related Categories
Hot ListMergers and Acquisitions
Trader Talk
Stocks Mentioned
+0.06Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
